Your browser is no longer supported. Please, upgrade your browser.
Settings
TMO Thermo Fisher Scientific Inc. daily Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E39.84 EPS (ttm)9.18 Insider Own0.10% Shs Outstand397.00M Perf Week4.02%
Market Cap142.09B Forward P/E25.20 EPS next Y14.52 Insider Trans-39.34% Shs Float394.09M Perf Month5.39%
Income3.70B PEG3.99 EPS next Q2.53 Inst Own91.70% Short Float0.93% Perf Quarter27.24%
Sales25.65B P/S5.54 EPS this Y22.10% Inst Trans-1.51% Short Ratio2.26 Perf Half Y12.11%
Book/sh71.94 P/B5.09 EPS next Y16.43% ROA6.30% Target Price364.94 Perf Year19.80%
Cash/sh7.96 P/C45.97 EPS next 5Y9.99% ROE12.60% 52W Range250.21 - 363.97 Perf YTD12.63%
Dividend0.88 P/FCF41.83 EPS past 5Y14.30% ROI8.50% 52W High0.53% Beta1.04
Dividend %0.24% Quick Ratio1.70 Sales past 5Y8.60% Gross Margin44.30% 52W Low46.23% ATR8.42
Employees75000 Current Ratio2.30 Sales Q/Q1.70% Oper. Margin17.90% RSI (14)63.67 Volatility2.31% 2.34%
OptionableYes Debt/Eq0.70 EPS Q/Q-0.10% Profit Margin14.30% Rel Volume0.70 Prev Close359.77
ShortableYes LT Debt/Eq0.67 EarningsApr 22 BMO Payout8.30% Avg Volume1.62M Price365.89
Recom1.80 SMA204.55% SMA506.79% SMA20015.54% Volume1,127,751 Change1.70%
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
May-30-19Initiated Wolfe Research Outperform
May-23-19Reiterated Needham Strong Buy $313 → $315
Apr-22-19Reiterated Needham Strong Buy $271 → $312
Apr-16-19Reiterated BofA/Merrill Buy $285 → $300
Jan-03-19Initiated Needham Strong Buy $271
Oct-18-18Downgrade Cleveland Research Buy → Neutral
Oct-09-18Initiated UBS Buy
Sep-24-18Reiterated Barclays Overweight $250 → $275
Sep-17-18Downgrade Goldman Buy → Neutral
Feb-01-18Reiterated Barclays Overweight $225 → $245
Jan-05-18Initiated BTIG Research Buy
Sep-06-17Resumed Morgan Stanley Overweight $220
Jul-03-20 12:38PM  
Jul-02-20 05:37PM  
12:10PM  
10:06AM  
08:11AM  
Jul-01-20 02:10PM  
09:45AM  
Jun-23-20 05:00PM  
Jun-22-20 11:22AM  
Jun-17-20 11:10AM  
Jun-16-20 11:58AM  
08:41AM  
08:37AM  
Jun-15-20 03:44PM  
Jun-10-20 12:23PM  
Jun-08-20 08:57PM  
Jun-04-20 10:20AM  
Jun-01-20 09:59AM  
09:58AM  
May-27-20 08:00AM  
05:00AM  
May-26-20 01:32PM  
May-22-20 11:30AM  
May-20-20 05:00PM  
May-19-20 10:57AM  
May-18-20 08:00AM  
07:00AM  
03:15AM  
May-16-20 09:15AM  
May-14-20 02:22PM  
11:51AM  
08:00AM  
May-13-20 04:44PM  
04:12PM  
03:53PM  
07:45AM  
May-12-20 04:05PM  
May-11-20 08:00AM  
May-06-20 04:50PM  
02:51PM  
08:00AM  
May-04-20 01:36PM  
Apr-22-20 04:33PM  
02:13PM  
10:25AM  
07:30AM  
06:30AM  
06:19AM  
06:15AM  
02:02AM  
Apr-17-20 09:43AM  
Apr-15-20 02:35PM  
12:31PM  
Apr-14-20 08:16AM  
Apr-13-20 03:45PM  
03:25PM  
Apr-10-20 03:37AM  
Apr-07-20 09:30AM  
Apr-06-20 02:59PM  
08:47AM  
08:30AM  
Apr-04-20 02:38PM  
07:18AM  
07:18AM  
Apr-03-20 09:37AM  
Apr-02-20 09:16AM  
Apr-01-20 01:31PM  
05:31AM  
Mar-31-20 03:26PM  
Mar-30-20 05:21PM  
05:06PM  
04:05PM  
04:41AM  
Mar-27-20 08:25PM  
07:44PM  
10:28AM  
09:44AM  
07:40AM  
Mar-26-20 02:00AM  
Mar-23-20 09:48PM  
05:30PM  
Mar-22-20 10:46AM  
Mar-21-20 06:14PM  
10:40AM  
Mar-20-20 08:00AM  
07:34AM  
Mar-19-20 04:32PM  
10:28AM  
09:14AM  
09:12AM  
07:58AM  
07:41AM  
Mar-18-20 06:42PM  
06:01PM  
04:24PM  
02:07PM  
11:32AM  
10:56AM  
09:56AM  
09:30AM  
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrodinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; and an agreement with Daiichi Sankyo to co-develop a companion diagnostic. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOJun 02Option Exercise124.2814,7951,838,723289,741Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 02Sale349.5514,7955,171,606274,946Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 01Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
Williamson StephenSr. VP and CFOJun 01Sale348.002,500870,00037,989Jun 02 04:21 PM
CASPER MARC NChairman & CEOJun 01Sale349.8920,0006,997,718274,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Sale349.2620,0006,985,200274,946Jun 02 04:19 PM
Stevenson MarkExecutive Vice President & COOMay 18Option Exercise124.2825,0003,107,00073,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Option Exercise124.2816,7052,076,097291,651May 20 05:07 PM
Stevenson MarkExecutive Vice President & COOMay 18Sale348.7825,0008,719,57548,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Sale349.4416,7055,837,472274,946May 20 05:07 PM
CASPER MARC NChairman & CEOApr 28Option Exercise124.2830,0003,728,400304,946Apr 29 04:22 PM
CASPER MARC NChairman & CEOApr 28Sale333.0230,0009,990,609274,946Apr 29 04:22 PM
Stevenson MarkExecutive Vice President & COOApr 24Option Exercise124.2825,0003,107,00073,538Apr 27 06:55 PM
Stevenson MarkExecutive Vice President & COOApr 24Sale328.0325,0008,200,65548,538Apr 27 06:55 PM
Williamson StephenSr. VP and CFOMar 04Option Exercise124.288,7001,081,23649,189Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Option Exercise124.2825,0003,107,00073,538Mar 05 04:59 PM
Williamson StephenSr. VP and CFOMar 04Sale318.548,7002,771,29840,489Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Sale324.2825,0008,107,00048,538Mar 05 04:59 PM
Lagarde MichelExecutive Vice PresidentMar 04Sale318.5412,0003,822,48026,385Mar 05 04:28 PM
Lagarde MichelExecutive Vice PresidentMar 03Sale319.8112,0003,837,72038,385Mar 05 04:28 PM
Williamson StephenSr. VP and CFOMar 02Sale291.032,500727,57540,489Mar 04 04:00 PM
CASPER MARC NChief Executive OfficerFeb 11Option Exercise124.2830,0003,728,400278,731Feb 13 04:07 PM
CASPER MARC NChief Executive OfficerFeb 11Sale337.1330,00010,114,048248,731Feb 13 04:07 PM
MANZI JIM PDirectorFeb 05Sale332.324,4101,465,53121,632Feb 06 04:32 PM
Williamson StephenSr. VP and CFOFeb 03Sale319.133,2681,042,91734,402Feb 05 05:59 PM
CASPER MARC NChief Executive OfficerOct 25Option Exercise73.2447,7293,495,672328,960Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerOct 25Sale295.8847,72914,121,958281,231Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerSep 13Option Exercise73.242,271166,328283,502Sep 17 04:54 PM
CASPER MARC NChief Executive OfficerSep 13Sale298.002,271676,758281,231Sep 17 04:54 PM
MANZI JIM PDirectorAug 15Sale272.931,833500,27927,892Aug 19 04:17 PM
CASPER MARC NChief Executive OfficerJul 30Option Exercise73.2450,0003,662,000342,193Jul 31 04:15 PM
CASPER MARC NChief Executive OfficerJul 30Sale284.8350,00014,241,366292,193Jul 31 04:15 PM